Loading BIIB charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading BIIB comparable companies…
| BIIBBiogen Inc.(opens in a new tab) | $37.48B | $10.30B | +2.3% | 74.0% | 22.9% | 3.64× | 109.3× |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc.(opens in a new tab) | $213.86B | $30.99B | +6.5% | 79.9% | −7.6% | 6.90× | — |
| NBIXNeurocrine Biosciences Inc.(opens in a new tab) | $15.23B | $3.37B | +34.4% | 98.0% | 23.6% | 4.51× | 21.4× |
| BNTXBioNTech SE(opens in a new tab) | $21.31B | $3.24B | +9.0% | 77.6% | −49.0% | 6.57× | — |
| AMGNAmgen Inc.(opens in a new tab) | $253.56B | $38.09B | +9.1% | 69.5% | 30.0% | 6.66× | 29.0× |
| Medianpeers, excl. BIIB | $117.58B | $17.18B | +9.1% | 78.8% | 8.0% | 6.61× | 25.2× |